RE:RE:remember this?TH is executing well on medical research in cancer and NASH, and Marsolais and his team deserve a ton of credit for that, but the issue is they are not getting much credit for that from the market because they have not been able to get investors interested in their progress. A slick video distributed in a way that investors might see it certainly would help. Can't see how it would hurt. Whatever TH has done regarding marketing their impressive progress to investors has clearly not worked very well, so TH should be open to new ideas.
qwerty22 wrote: They are executing on a medical research business and you're complaining about videos.
scarlet1967 wrote:
"3D animations are great support to explain the mechanism of action of a molecule. With the help of Amerra, we were able to convey how our promising peptide-drug conjugate technology works inside the body. Amerra produced such an amazing result at a cost a small biotech like us can afford. We're very much looking forward to working with them on our next animated video."
- Nichol Pelchat, Associate Director, New Product Planning
https://youtu.be/6iu07e1_us8
Yet they are quite generous with their compensations which was announced on a Friday afternoon thus less attention. So whose interest has been prioritized using the funds for a cash strapped company? the employees with fat bonuses or decent marketing to support the valuation of the company subsequently a decent ROI for their loyal long-term shareholders?